Name: Latest research reports of Ajanta Pharma Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Mid-range Performer

2638.5000 -18.00 (-0.68%)

NSE Aug 22, 2025 15:31 PM

Volume: 51,046

Ajanta Pharma Ltd.

04 Nov 2022

2638.50

-0.68%

Ajanta Pharma (HOLD): No respite from margin pressure; cut to HOLD

Hold: Ajanta Pharma Ltd.

BOB Capital Markets Ltd.

Q2 revenue growth muted at 6% YoY as lower Africa/US sales offset a strong uptick in India/Asia business

Ajanta Pharma Ltd.'s price crossed below 50Day SMA today